Ulrik Abildgaard

Copenhagen, 2900, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Age- and sex-based normal reference ranges of the cardiac time intervals: the Copenhagen City Heart Study.

Age- and sex-based normal reference ranges of the cardiac time intervals: the Copenhagen City Heart Study.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: January 22, 2023

Changes in cardiac time intervals over a decade and the risk of incident heart failure: The Copenhagen City Heart Study.

Changes in cardiac time intervals over a decade and the risk of incident heart failure: The Copenhagen City Heart Study.

Journal: International journal of cardiology

Published: January 01, 2023

Prognostic Value of Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.

Prognostic Value of Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.

Journal: Journal of the American College of Cardiology

Published: September 16, 2020

SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease.

SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease.

Journal: Scandinavian cardiovascular journal : SCJ

Published: May 14, 2020

Left ventricular systolic ejection time is an independent predictor of all-cause mortality in heart failure with reduced ejection fraction.

Left ventricular systolic ejection time is an independent predictor of all-cause mortality in heart failure with reduced ejection fraction.

Journal: European journal of heart failure

Published: April 20, 2020

16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.

16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.

Journal: European heart journal

Published: June 27, 2019

Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

Journal: Journal of the American College of Cardiology

Published: June 17, 2019

Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

Journal: Circulation

Published: December 20, 2018

Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II.

Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II.

Journal: PloS one

Published: August 14, 2018

Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments.

Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: July 04, 2018

10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents.

10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents.

Journal: Journal of the American College of Cardiology

Published: July 28, 2016

Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.

Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.

Journal: The New England journal of medicine

Published: May 19, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026